Investigator initiated clinical trial of cancer vaccine OCV-C01 in advanced and recurrent biliary tract cancer
Mutsunori Murahashi(Jikei University School of Medicine), Kenzaburo Tani(Tokyo Medical University), Koji Todaka(Kyushu University Hospital), Kazunari Yamada(Kyushu University Hospital), Kouta Funakoshi(Kyushu University Hospital), Hisanobu Ogata(Kyushu University), Yasuki Hijikata(Kyushu University Hospital), Toshihiko Okazaki(Johns Hopkins University), Yoichi Nakanishi(RIKEN Center for Integrative Medical Sciences), Toshihisa Tsuruta(Nagoya University Hospital), Junji Kishimoto(Kyushu University Hospital)
Cited by 1
Related Papers
Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis
|Human Molecular Genetics|2003|337
Loss of Suppressor of Cytokine Signaling 1 in Helper T Cells Leads to Defective Th17 Differentiation by Enhancing Antagonistic Effects of IFN-γ on STAT3 and Smads
|The Journal of Immunology|2008|183
Deletion of the SOCS3 Gene in Liver Parenchymal Cells Promotes Hepatitis–Induced Hepatocarcinogenesis
|Gastroenterology|2006|180
Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L
|Journal of Clinical Oncology|2016|160